Cellular immunity to acetylcholine receptor in myasthenia gravis

To debermine the nature of the cellular immune response directed against acetylcholine receptor in myasthenia gravis, we compared lymphocyte stimulation by eel receptor with clinical factors. The mean (k SEM) stimulation index wa.s 4.5 ± 0.9 for 39 myasthenic patients and 0.97 ± 0.18 for 48 controls (p < 0.001). Positive response in patients was associated with disease onset after 50 years (10 of 13 patients) and presence of thymoma (seven of eight patients), but not with HLA type. Stimulation index correlated with disease activity (rs = 0.6 3, < 0.01). Blocking the active portion of the receptor molecule with naja toxin resulted in 68 percent diminution of the response, suggesting that this site plays a significant role in the cellular immune response in myasthenia gravis.

[1]  J. Lindstrom,et al.  Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. , 1977, The New England journal of medicine.

[2]  J. Davis,et al.  REMISSION OF MYASTHENIA GRAVIS FOLLOWING PLASMA-EXCHANGE , 1976, The Lancet.

[3]  J. Lindstrom,et al.  Antibody to acetylcholine receptor in myasthenia gravis , 1976, Neurology.

[4]  W. Sheremata,et al.  MYASTHENIA GRAVIS, MULTIPLE SCLEROSIS, AND CELLULAR SENSITIZATION TO ACETYL CHOLINE RECEPTOR PROTEIN: 55 , 1976 .

[5]  J. Lindstrom,et al.  EXPERIMENTAL AUTOIMMUNE MYASTHENIA GRAVIS AND MYASTHENIA GRAVIS: BIOCHEMICAL AND IMMUNOCHEMICAL ASPECTS * , 1976, Annals of the New York Academy of Sciences.

[6]  D. Richman,et al.  Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. , 1976, The New England journal of medicine.

[7]  A. Pestronk,et al.  Myasthenia gravis: passive transfer from man to mouse , 1975, Science.

[8]  R. Almon,et al.  Acetylcholine receptor antibodies in myasthenia gravis. , 1975, The New England journal of medicine.

[9]  S. Fuchs,et al.  HUMORAL ANTIBODIES TO ACETYLCHOLINE RECEPTOR IN PATIENTS WITH MYASTHENIA GRAVIS , 1975, The Lancet.

[10]  W. Engel,et al.  MYASTHENIA GRAVIS: A SERUM FACTOR BLOCKING ACETYLCHOLINE RECEPTORS OF THE HUMAN NEUROMUSCULAR JUNCTION , 1975, The Lancet.

[11]  C G Andrew,et al.  Serum Globulin in Myasthenia Gravis: Inhibition of α-Bungarotoxin Binding to Acetylcholine Receptors , 1974, Science.

[12]  S. Horowitz,et al.  HL-A ANTIGENS IN MYASTHENIA GRAVIS , 1974 .

[13]  F. Naeim,et al.  HL-A antigens in myasthenia gravis. , 1974, Lancet.

[14]  H. Oosterhuis,et al.  Myasthenia Gravis, Autoantibodies, and HL-A Antigens , 1974, British medical journal.

[15]  J. Patrick,et al.  Studies on purified eel acetylcholine receptor and anti-acetylcholine receptor antibody. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Patrick,et al.  Autoimmune Response to Acetylcholine Receptor , 1973, Science.

[17]  H. Mcdevitt,et al.  Histocompatibility-linked immune response genes. , 1972, Science.

[18]  A. Penn.  Myasthenia gravis, dermatomyositis, and polymyositis: immunopathological diseases. , 1977, Advances in neurology.

[19]  J. Lindstrom.  Immunological studies of acetylcholine receptors. , 1976, Journal of supramolecular structure.

[20]  S. Fuchs,et al.  Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis. , 1975, Clinical and experimental immunology.